
Thangavelu Saravanan
About Thangavelu Saravanan
Data last updated:
Thangavelu Saravanan is a Director at Abirami Kidney Care Private Limited (since 2019), Director at Sree Ss Pharma Private Limited (since 2019) and Director at Four Square Medical Centre And Hospital Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Healthcare, Pharma and Real Estate. The 3 current companies with reported revenue have a combined latest revenue of ₹20.71 Cr; the largest is Abirami Kidney Care Private Limited at ₹11.63 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Jan 2019 | 2019 | ₹11.63 Cr (FY 2025) | Active | |
| Director | 24 Dec 2019 | 2019 | ₹7.51 Cr (FY 2025) | Active | |
| Director | 30 Aug 2021 | 2021 | ₹1.58 Cr (FY 2025) | Active | |
| Director | 03 Apr 2025 | 2025 | Active | ||
| Partner | 30 Sep 2023 | 2014 | Active |
Board colleagues of Thangavelu Saravanan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jambai Munirajah Jayaprakash | 02066229 | Abirami Kidney Care Private Limited | Additional Director |
| Thangavelu Kalavathi | 08984628 | Abirami Kidney Care Private Limited , Sree Ss Pharma Private Limited and 2 more | Director |
| Chidambaram Natarajan Raman | 06841323 | Karur Doctors Pharma Llp | Designated Partner |
| Elango Ravirajasekar | 06852851 | Karur Doctors Pharma Llp | Designated Partner |
| Kulandaiappan Chellappan Balasubramaniam | 06790999 | Karur Doctors Pharma Llp | Designated Partner |
| Manohar Rajalingam | 02049522 | Karur Doctors Pharma Llp | Designated Partner |
| Rengasamy Karuppaiya | 01295092 | Karur Doctors Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Thangavelu Saravanan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thangavelu Saravanan
Thangavelu Saravanan currently holds 5 directorships: Abirami Kidney Care Private Limited (Director, since 09 Jan 2019, revenue ₹11.63 Cr (FY 2025)); Sree Ss Pharma Private Limited (Director, since 24 Dec 2019, revenue ₹7.51 Cr (FY 2025)); Four Square Medical Centre And Hospital Private Limited (Director, since 30 Aug 2021, revenue ₹1.58 Cr (FY 2025)); Sri Lalitham Realty Services Private Limited (Director, since 03 Apr 2025); Karur Doctors Pharma Llp (Partner, since 30 Sep 2023).
Thangavelu Saravanan was first appointed on 09 Jan 2019 as Director at Abirami Kidney Care Private Limited. The most recent appointment on record is 03 Apr 2025 at Sri Lalitham Realty Services Private Limited.
The 3 current companies of Thangavelu Saravanan that report revenue have a combined latest revenue of ₹20.71 Cr: Abirami Kidney Care Private Limited ₹11.63 Cr (FY 2025); Sree Ss Pharma Private Limited ₹7.51 Cr (FY 2025); Four Square Medical Centre And Hospital Private Limited ₹1.58 Cr (FY 2025).
The current boards of Thangavelu Saravanan's companies include Jambai Munirajah Jayaprakash (Abirami Kidney Care Private Limited), Thangavelu Kalavathi (Abirami Kidney Care Private Limited), Chidambaram Natarajan Raman (Karur Doctors Pharma Llp), Elango Ravirajasekar (Karur Doctors Pharma Llp), Kulandaiappan Chellappan Balasubramaniam (Karur Doctors Pharma Llp), Manohar Rajalingam (Karur Doctors Pharma Llp), among others.